期刊文献+

经桡动脉入径冠状动脉造影术后并发指动脉血栓形成1例 被引量:4

下载PDF
导出
摘要 1临床资料患者女,62岁。因“经桡动脉入径行冠状动脉造影术后15 h,突发右手指疼痛6 h”于2019年5月30日收入杭州市余杭区第一人民医院。患者因“反复心悸2年”于我院住院行经右桡动脉入径行冠状动脉造影示:左主干开口于右冠状窦,左主干、左回旋支未见明显狭窄,左前降支中段一肌桥,收缩期30%狭窄,舒张期恢复,右冠状动脉未见明显狭窄。术前查血尿便常规、凝血功能、D-二聚体、肝肾功能、电解质、心肌酶谱均无异常,术后予桡动脉压迫止血器压迫4 h后出院。
出处 《中国介入心脏病学杂志》 2020年第8期479-480,共2页 Chinese Journal of Interventional Cardiology
  • 相关文献

参考文献3

二级参考文献27

  • 1Montalescot G, White HD, Gallo R, et al. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention. N Engl J Med, 2006, 355 : 1006-1017.
  • 2Ferguson JJ, Califf RM, Antman EM, et al. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA, 2004, 292: 45-54.
  • 3Amman EM,Morrow DA, McCabe CH, et al. Enoxaparin versus unfractionated heparin with fi brinolysis for ST-elevation myocardial infarction. N Engl J Med, 2006, 354: 1477-1488.
  • 4Anderson JL,Adams CD, Antman EM, et al. 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol, 2013, 61: e179- e347.
  • 5Bittl JA, Strony J, Brinker JA, et al. Treatment with bivalirudin (hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. N Engl J Med, 1995, 333 : 764-769.
  • 6Lineoff AM, Bittl JA, Kleiman NS, et al. Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to reduced Clinical Events [ REPLACE] 1 trial). Am J Cardiol, 2004, 93 : 1092-1096.
  • 7Lineoff AM, Bittl JA, Harrington RA, et al. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention : REPLACE 2 randomized trial. JAMA, 2003,289 : 853-863.
  • 8Parodi G, Migliorini A, Valenti R, et al. Comparison of bivalirudin and unfractionated heparin plus protamine in patients with coronary heart disease undergoing percutaneous coronary intervention (from the Antithrombotic Regimens and Outcome [ ARNO] trial). Am J Cardiol, 2010, 105 : 1053-1059.
  • 9Ebrahimi R,Lincoff AM, Bittl JA, et al. Bivalirudin vs heparin in percutaneous coronary intervention: a pooled analysis. J Cardiovasc Pharmacol Ther, 2005, 10: 209-216.
  • 10De LucaG, Cassetti E, Verdoia M, et al. Bivalirudin as compared to unfractionated heparin among patients undergoing coronary angioplasty: A meta-analyis of randomised trials. Thromb Haemost,2009, 102: 428-436.

共引文献46

同被引文献43

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部